Evidence map›Paper›PMID 28005306›Full record

ArticleMicrocirculation (New York, N.Y. : 1994)2017

Nonenzymatic glycation interferes with fibronectin-integrin interactions in vascular smooth muscle cells.

Srijita Dhar, Zhe Sun, Gerald A Meininger, Michael A Hill

Open access · bronzeAbstract read
In one paragraph

Article in Microcirculation (New York, N.Y. : 1994), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Extracellular matrix dynamics in vascular remodeling.American journal of physiology. Cell physiology · 2020
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Srijita DharDalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
Zhe SunDalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
Gerald A MeiningerDalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
Michael A HillDalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.ORCID 0000-0002-4455-2072
University of Missouri · US

Funding

Role of Cytokine-Induced Inflammation in Endothelial Dysfunction in DiabetesR01HL085119 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HILL, MICHAEL A · 2007 to 2015
$3.1M
NHLBI NIH HHS R01 HL085119
6 · The paper itself

Abstract

objectiveWe aimed to investigate whether advanced nonenzymatic glycation of the ECM protein, fibronectin, impacts its normal integrin-mediated interaction with arteriolar VSMC.

methodsAFM was performed on cultured VSMC from rat cremaster arterioles to study native and glycated fibronectin (FN and gFN) interactions with cellular integrins. AFM probes were functionalized with FN or gFN or with native or glycated albumin (gAlb) as controls.

resultsVSMC showed increased adhesion probability to gFN (72.9±3.5%) compared with native FN (63.0±1.6%). VSMC similarly showed increased probability of adhesion (63.8±1.7%) to gAlb compared with native Alb (40.1±4.7%). Adhesion of native FN to VSMC was α5 and β1 integrin dependent whereas adhesion of gFN to VSMC was integrin independent. The RAGE-selective inhibitor, FPS-ZM1, blocked gFN (and gAlb) adhesion, suggesting that adhesion of glycated proteins was RAGE dependent. Interaction of FN with VSMC was not altered by soluble gFN while soluble native FN did not inhibit adhesion of gFN to VSMC. In contrast, gAlb inhibited adhesion of gFN to VSMC in a concentration-dependent manner.

conclusionsGlycation of FN shifts the nature of cellular adhesion from integrin- to RAGE-dependent mechanisms.

Indexed as

Cell AdhesionAnimalsArteriolesFibronectinsGlycated ProteinsGlycated Serum AlbuminGlycation End Products, AdvancedGlycosylationIntegrinsMuscle, Smooth, VascularMyocytes, Smooth MuscleRatsReceptor for Advanced Glycation End ProductsSerum AlbuminAger protein, ratFibronectinsglycated fibronectinGlycated ProteinsGlycated Serum AlbuminGlycation End Products, AdvancedIntegrinsReceptor for Advanced Glycation End ProductsSerum Albuminadhesionadvanced glycation end productsatomic force microscopyextracellular matrix proteinsintegrinsreceptor for advanced glycation end productsresistance arteries

Identifiers

PMID28005306
PMCPMC5404995
OpenAlexW2562073383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.